TOOLS FOR GLOBAL FUND ADVOCACY
use our search bar at top or tag system on the right to find what you need
-
Jul 2019 Sustainable Health Financing Advocacy +
Publisher: GFAN
Civil Society Advocacy for Sustainable Financing for Health Sustainable Health Financing Advocacy
Concept Note: As a broad framework, Sustainable health financing advocacy (SHFa) encompasses advocacy across multiple health priorities and in multiple health financing contexts. This unified framework for action can help advocates align efforts, understand the interlinkages and potential synergies for collaboration, and avoid silos in our work.
Download the Full Report here.
Download the Executive Summary here.
-
Jul 2019 Global AIDS update 2019 — Communities at the centre +
Publisher: UNAIDS
When communities organize and people empower each other, oppression can be replaced by rights and access to HIV services can be accelerated. Peer-to-peer counsellors, community health workers, door-to-door service providers, grass-roots activists and networks of people living with or affected by HIV all have key roles to play in the response to HIV. As this report shows, community leadership in the AIDS response helps to ensure that HIV services are relevant to, and reach, the people who need them the most.
-
Jul 2019 Getting local: focusing on communities to achieve greater impact in the next phase of the HIV response +
Publisher: Journal of the International AIDS Society
Despite numerous achievements in addressing HIV epidemics worldwide, there is still much more that needs to be done to control HIV as a public health threat. As such, the world is at a critical juncture in the HIV response. Decelerating the response now would reverse the enormous gains achieved so far. Achieving a greater impact in the next phase of the HIV response requires an improvement in the quality and integration of services to make the services align to the identified needs of communities.
-
Jul 2019 Are monitoring and evaluation systems adequate to report the programmatic coverage of HIV services among key populations in countries? +
Publisher: Infectious Diseases of Poverty
There was no global guidance or agreement regarding when a country has an adequate system to report on the service packages among human immunodeficiency virus (HIV) key populations. This article describes an approach to categorizing the system in a country for reporting the service package among HIV key populations. The approach consists of four dimensions, namely the epidemiological significance, comprehensiveness of the service packages, geographic coverage of services, and adequacy of the monitoring system. The proposed categorization approach utilizes available information and can inform the improvement of the service delivery and monitoring systems among HIV key populations.
-
Jul 2019 Delivering Quality-assured Medical Products for All 2019–2023 +
Publisher: World Health Organization
Universal health coverage will bring about greater access to medical products, but we must ensure that those products are quality-assured, safe and effective so that they do what they are supposed to do – prevent illness and improve people’s health. That is why today’s launch of WHO’s five-year plan ‘Delivering Quality-assured Medical Products for All 2019–2023’ is important.
-
Jun 2019 The Global Fund: An Extraordinary Investment +
The Global Fund has a history of doing extraordinary work: few investments have had the impact that the Global Fund has in saving lives, preventing infections and creating strong and resilient health systems. The Global Fund’s Investment Case outlines the absolute minimum level of investment needed to address HIV/AIDS, TB and malaria over the next 3 years when in fact, we are at a critical moment where the minimum may not be enough to prevent us from sliding back.
-
Jun 2019 Tackling the Triple Transition in Global Health Procurement +
Publisher: Center for Global Development
Within a changing global health landscape, a forward-looking approach is needed to anticipate tomorrow’s challenges and plan for the future. To this end, the Center for Global Development convened the Working Group on the Future of Global Health Procurement to review the evidence and formulate recommendations for how the global health community—international health organizations, their bilateral and foundation donors, and low- and middle-income countries—can ensure the medium- to long-term relevance, efficiency, quality, affordability, and security of global health procurement. Importantly, the group limited its focus to the procurement process: the journey of a health product from manufacturer to a centralized warehouse or other wholesaling facility. The downstream supply chain and delivery process—a product’s journey from warehouse to end user—was beyond the Working Group’s scope.
-
Jun 2019 The Challenges of Transition From Donor-Funded Programs +
Publisher: Global Health: Science and Practice
In the era of declining development assistance for health, transitioning externally funded programs to governments becomes a priority for donors. However, the process requires a careful approach not only to preserve the public health gains that have already been achieved but also to expand on them. In the Eastern Europe and Central Asia region, countries are expected to graduate from support from the Global Fund to Fight AIDS, Tuberculosis and Malaria in or before 2025. We aim to describe transition risks and identify possible means to address them.
-
May 2019 The economics of malaria control in an age of declining aid +
Publisher: Nature Communications
This article examines financing in the fight against malaria. After briefly describing malaria control plans in Africa since 2000, it offers a stylized model of the economics of malaria and shows how health aid can help escape the malaria trap.
-
May 2019 Addressing the structural drivers of HIV: A STRIVE synthesis +
Publisher: STRIVE
The past two decades have seen significant progress in tackling HIV. Behavioural interventions have curbed rates of transmission. The scale up of HIV treatment has not only reduced levels of morbidity and mortality, but also created new opportunities for HIV prevention. However, mathematical modelling suggests that, with the current rate of antiretroviral therapy (ART) initiation, 49 million more new HIV infections will occur by 2035, and that even at best, with 90 to 95% coverage, treatment will avert only 60% of new infections.